Lack of SPI-14 decreased <i>S</i>. Typhimurium virulence in mice by affecting intestinal invasion. by Lingyan Jiang (4063771)

Decreased epithelial PGR expression in <i>Arid1a</i>^<i>d/d</i> mice. by Tae Hoon Kim (128536)

Cognitive mechanisms for inferring the meaning of novel signals during symbolisation - Fig 5 by Justin Sulik (4768296)

Decrease in IL-4 measured by standard ELISA. by Albert S. Jun (231619)

“…Each ELISA value is an average of two measurements. The decrease in IL-4 in the keratoconus pool (7.6±5 pg/ml), compared to controls (14.2±8.6 pg/ml) was statistically significant (p≤0.05, Mann-Whitney test). …”

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

Decrease of 4 Asp isomers at 70°C. by Kenzo Aki (386666)

“…<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0058515#pone-0058515-g007" target="_blank">Figure 7a:</a> decrease of L-α-Asp with incubation of T6-Lα peptide at 70°C. …”

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Increased cross-sectional tongue area and sustained OSA at 8 weeks after PTFE injection. by Simon Lebek (9756148)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation by Mirzokhid Rakhmanov (580449)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”